Sign in

NCT04450459Completed

Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.

Impact of Ergospirometric Oxygen Uptake Under Exercise as Diagnostic Marker of Cardiac Ischemia in Patients With Stable Angina Compared to Non Invasive and Invasive (FFR) Measurement of Ischemia

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection. Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.

Status (registry)
Completed
Study type
Observational
Enrollment
121 (actual)
First submitted
25 Jun 2020
Start date
2 Jan 2019
Primary completion date
25 Aug 2025
Lead sponsor
Jena University Hospital
NCT number
NCT04450459

What you commit to

  • Study type: Observational
  • Participants enrolled: 121
  • From 2 Jan 2019 to the primary completion date, 25 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unstable angina or myocardial infarction within the last 2 weeks
  • significant valvular disease

Other

  • inability to perform bicycle exercise test
  • HOCM
  • av- block \>I degree
  • asthma bronchiales

Who the study is looking for

  • stable Angina (CCS \>1-3) with suspected CAD or
  • dyspnoea at exertion NYHA \>2 or
  • signs of ischemia within SPECT or exercise electrocardiography
  • willingness to participate in the trial

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universityhospital
Coordinator of this site? Confirm its status
JenaGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.